These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S, Vilgrain V. Eur J Radiol; 2013 May; 82(5):e205-11. PubMed ID: 23273822 [Abstract] [Full Text] [Related]
5. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. Zocco MA, Garcovich M, Lupascu A, Di Stasio E, Roccarina D, Annicchiarico BE, Riccardi L, Ainora ME, Ponziani F, Caracciolo G, Rapaccini GL, Landolfi R, Siciliano M, Pompili M, Gasbarrini A. J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306 [Abstract] [Full Text] [Related]
14. Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities. Meijerink MR, van Waesberghe JH, van Schaik C, Boven E, van der Veldt AA, van den Tol P, Meijer S, van Kuijk C. Ultrasound Med Biol; 2010 Oct; 36(10):1626-36. PubMed ID: 20800954 [Abstract] [Full Text] [Related]
15. Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study. Sacco R, Faggioni L, Bargellini I, Ginanni B, Battaglia V, Romano A, Bertini M, Bresci G, Bartolozzi C. Dig Liver Dis; 2013 Sep; 45(9):776-81. PubMed ID: 23578581 [Abstract] [Full Text] [Related]